IP Library Granted Patent US 7,541,355
Granted Patent B2
US 7,541,355 · App. 11/135,100 · Granted Jun 2, 2009

Conversion process for 2,3-benzodiazepine enantiomers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,541,355
App. No.
11/135,100
Granted
Jun 2, 2009
Kind
B2
Abstract

Methods for the racemization of an enantiomer of a 2,3-benzodiazepine molecule into the corresponding racemic mixture under either basic or acidic conditions are described. Furthermore, the invention relates to the conversion of an enantiomer of tofisopam or its metabolites to the corresponding opposite enantiomer.

Claims (18)

1. A method for racemizing an enantiomer of tofisopam to its racemate, the method comprising (a) reacting the enantiomer with one or greater base equivalent of an organic base at a temperature below 20° C. and (b) quenching the reaction with a proton source, thereby obtaining the racemate from the enantiomer.

2. The method according to claim 1 , wherein the enantiomer is S-tofisopam.

3. The method according to claim 1 , wherein the enantiomer is R-tofisopam.

4. The method according to claim 1 , wherein the organic base is potassium t-butyloxide.

5. The method according to claim 1 , wherein the proton source is water or camphorsultam.

6. A method for increasing the yield of a desired enantiomer of tofisopam over an undesired, the method comprising (a) obtaining the undesired enantiomer, (b) reacting the undesired enantiomer with one or greater base equivalent of an organic base at a temperature below 20° C., (c) quenching the reaction with a proton source thereby obtaining a racemate from the undesired enantiomer, and (d) isolating the desired enantiomer from the racemate of step (c).

7. The method according to claim 6 , wherein the desired enantiomer is S-tofisopam.

8. The method according to claim 6 , wherein the desired enantiomer is R-tofisopam.

9. The method according to claim 6 , wherein the organic base is potassium-t-butyloxide.

10. The method according to claim 6 , wherein the proton source is water.

11. A method for racemizing an enantiomer of tofisopam to its racemate, the method comprising (a) reacting the enantiomer with an organic or inorganic acid at an elevated temperature in a high temperature boiling organic solvent selected from the group consisting of dimethylsulfoxide, toluene and dioxane and (b) obtaining the racemate from the enantiomer.

12. The method according to claim 11 , wherein the enantiomer is S-tofisopam.

13. The method according to claim 11 , wherein the enantiomer is R-tofisopam.

14. The method according to claim 11 , wherein the organic acid is selected from the group consisting of camphor sulfonic acid and dibenzoyl-D/L-tartaric acid.

15. A method for increasing the yield of a desired enantiomer of tofisopam from a racemic mixture, the method comprising (a) obtaining the undesired enantiomer, (b) reacting the undesired enantiomer with an organic acid at an elevated temperature in a high temperature boiling organic solvent selected from the group consisting of dimethylsulfoxide, toluene and dioxane, thereby obtaining a racemate from the undesired enantiomer, and (c) isolating the desired enantiomer from the racemate of step (b).

16. The method according to claim 15 , wherein the desired enantiomer is S-tofisopam.

17. The method according to claim 15 , wherein the desired enantiomer is R-tofisopam.

18. The method according to claim 15 , wherein the organic acid is selected from the group consisting of camphor sulfonic acid and dibenzoyl-D/L-tartaric acid.

Assignments (7)
TO ADD RECEIVING PARTY'S ADDRESS Recorded Jan 3, 2007
From: VELA PHARMACEUTICALS INC.
To: VELA ACQUISITION CORPORATION
Reel/Frame 018700/0352 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2005
From: SHI, JIANFENG
To: VELA PHARMACEUTICALS, INC.
Reel/Frame 016905/0015 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2005
From: WEI, YONG VICTORIA
To: VELA PHARMACEUTICALS, INC.
Reel/Frame 016905/0022 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2005
From: YE, NAIDONG; GALBRAITH, KIMM B.
To: VELA PHARMACEUTICALS, INC.
Reel/Frame 016905/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2005
From: WANG, WUYI
To: VELA PHARMACEUTICALS, INC.
Reel/Frame 016905/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2005
From: RAVI, MALLIKARJUN REDDY
To: VELA PHARMACEUTICALS, INC.
Reel/Frame 016905/0031 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2005
From: XU, YUNGEN
To: VELA PHARMACEUTICALS, INC.
Reel/Frame 016905/0040 →